Lactate Dehydrogenase L-P (LDH) (NAD) (2020-08-15)

Starting date:

August 15, 2020

Posting date:

August 28, 2020

Type of communication:

Medical Device Recall

Subcategory:

Medical Device

Hazard classification:

Type II

Source of recall:

Health Canada

Issue:

Medical Devices

Audience:

General Public, Healthcare Professionals, Hospitals

Identification number:

RA-73799

Last updated: 2020-08-28

• Reason
• Affected products

Affected Products

Lactate Dehydrogenase L-P (LDH) (NAD)

Reason

Randox have released an update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate dehydrogenase assay on Rx instruments. Additional pipette washes can be implemented as described in the technical bulletin.

Affected products